Medical malpractice legislation advancing in Congress

The House Judiciary Committee has approved legislation that would cap punitive damages in medical malpractice cases at $250,000 when it involves patients covered under Medicare, Medicaid, veterans or military health plans or plans on Affordable Care Act (ACA) exchanges.

The bill, sponsored by U.S. Rep. Steve King, R-Iowa, is based on California’s medical liability reforms, the Medical Injury Compensation Reform Act (called MICRA). According to the Republican majority on the committee, the legislation wouldn’t limit noneconomic damages to injured patients, but would reduce malpractice premiums by up to 30 percent.

“The Protecting Access to Care Act will help keep the rising costs of healthcare from being passed along to the American people,” said Judiciary Committee Chairman Bob Goodlatte, R-Virginia. “The Congressional Budget Office estimates that the reforms contained in the bill would lower health care costs by tens of billions of dollars.”

The bill advanced despite resistance from Democrats. The ranking member on the committee, U.S. Rep. John Conyers, D-Michigan, said the bill is aimed at protecting the medical industry at the expense of patients.

“It is hard to know why a provider should be entitled to blanket immunity for dispensing a defective or dangerous pharmaceutical or medical device,” Conyers said at the beginning of the hearing. “This provision also has the potential to indirectly shield pharmaceutical and device manufacturers, who may be able to argue successfully in a product liability action that a plaintiff’s injury can be blamed on a provider’s negligence.”

Malpractice reform had been a favorite subject of HHS Secretary Tom Price, MD, when he served in Congress. He once proposed moving malpractice cases out of the court system to state tribunals with at least half of its members being doctors or healthcare professionals. 

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.